
Surgeon I PhD in #epigenetics #mitochondria #livertranplant @UniMelbMDHS I former Chair @VERITAS_Collab I Aquarius I Views ➡️ own I 🇬🇧🇦🇺
Joined February 2009
- Tweets344
- Following647
- Followers322
- Likes1K
Daniel Cox retweeted
1/ When starting a🤖Whipple program, struggle is always balancing patient selection for safe completion vs⬇️volume w being selective.
We asked if it was safe w being liberal w pt selection w a lower threshold to convert for non-progression. Results in🧵!
sciencedirect.com/science/ar…
With robust clinical evidence for #MachinePerfusion (MP) for #LiverTransplantation…it is here to stay. But how do transplant departments develop their machine perfusion services? Cost is a key factor 💰Our latest paper in @TransplantJrnl reviews the evidence for cost-effectiveness of MP. These data are critical to develop institutional and policy-level investment in MP technologies🏥@Murali_HPBSurg @austin_HRG @SoMeTransplant @TSANZ_txsoc
journals.lww.com/transplantj…
Excellent day at the @BTStransplant International Liver Transplant Oncology Symposium @ Kings. Lots to think about, 💎 from the frontline of this re-emerging field. And so good to catch up with a few friends! 🇬🇧🇦🇺 @DrGERidd @Murali_HPBSurg @GutFailure @OxTxResearch @austin_HRG
Daniel Cox retweeted
The dying specialty of “General Surgery”, as noted by authors from each and every decade over the last 100 years.
Daniel Cox retweeted
@uhbtrust @Bham_HPB_LTx @BridgetoLifeLTD @NeilRajJ1 @UHB_HPB 2nd UK National HOPE meeting. George Clark pc the evolution of machine perfusion in #livertransplant @uhbtrust. Game changer with lack of DBD offers nationally
Daniel Cox retweeted
Great to have Dr Varuna Aluvihare coming from the world class Kings Liver unit to deliver a talk on post-LT IS in Birmingham. Food for thought, great review of data, & pleasure to hear his experiences. Thank you and here’s to more Birmingham-Kings sessions/cross-pollination
Daniel Cox retweeted
🆕Online today: Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable #pancreaticpancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
@BasGrootKoerkam, @MarcBesselink, Dutch Pancreatic Cancer Group
thelancet.com/journals/lanon…
Daniel Cox retweeted
MitoArt — may the bioenergetic boat/hypothesis of health and disease take us closer to the truth
Daniel Cox retweeted
We're saddened to hear of the passing of A/Prof Alexander Dobrovic @AlexDobrovic. A dedicated cancer researcher and epigeneticist, his lab was at the forefront of bringing epigenetic based tests into the clinic. 1/3
Daniel Cox retweeted
Today Mass General Hospital has announced the world’s first successful transplant of a genetically-edited pig (porcine) kidney into a 62-year-old man living with end-stage kidney disease.
Check out the article: massgeneral.org/news/press-r…
Daniel Cox retweeted
Congratulations @COXdaniel on your exceptional PhD thesis. 👏🏽👏🏽 Very proud to be able to hold the printed volume , a work of scientific art.
Glad to have been on this journey with you. The future is extremely bright. Thank you fellow supervisors @TGEG_ResDx and @GutFailure.
Harnessing #cfDNA🧬to enhance precision in #livertransplant care..take a look at the next step in our research in @TransplantJrnl➡️analysing #mitochondria-derived cfDNA as a potential, objective tool to help evaluate graft viability for Tx during warm machine perfusion(@organ_ox)
Daniel Cox retweeted
'Hospital at home' could be the future of health care.
Not everyone thinks it's a good idea ti.me/3FfNM0d
Hugely inspiring session 🔥on the future of machine perfusion at #ESOTcongress this AM from @gabriel_oniscu @Paulo_MartinsMD Marcelo Cypel et al. What an exciting time to be an aspiring academic surgeon in Tx. 🥼🧬#perfusiontherapeutics
#perfusionpersonalisation
So good to see @ESOTtransplant taking the lead and having a serious look at the role of novel non-invasive biomarkers in enhancing liver Tx care🏥 glad that some of our work could help inform this 🧬@Murali_HPBSurg
@GutFailure @TGEG_ResDx @Austin_Health @sukahgoh

























